MA S 1603
in committeeAn Act to conduct a public health study of synthetic drugs in the commonwealth
Massachusetts · 2025-2026 Regular Session (194th General Court) · upper
Quick answers
Did MA S 1603 pass?
Not yet. MA S 1603 is in committee as of 2025-12-04 and has not come to a final vote. Latest recorded action (2025-12-04): Accompanied a study order, see S2790
What is MA S 1603 about?
By Mr. O'Connor, a petition (accompanied by bill, Senate, No. 1603) of Patrick M. O'Connor for legislation to conduct a public health study of synthetic drugs in the commonwealth. Public Health.
Who sponsors MA S 1603?
Patrick M. O'Connor is the primary sponsor of MA S 1603.
Description
By Mr. O'Connor, a petition (accompanied by bill, Senate, No. 1603) of Patrick M. O'Connor for legislation to conduct a public health study of synthetic drugs in the commonwealth. Public Health.
- Introduced
- —
- Latest action
- 2025-12-04 — Accompanied a study order, see S2790
- Bill type
- bill
- Last updated
- —
Sponsors
- Patrick M. O'Connorprimary
Committees
Not provided by source.
Action timeline
2025-02-27
Referred to the committee on Public Health
referral-committee
2025-02-27
House concurred
2025-06-06
Hearing scheduled for 06/11/2025 from 01:00 PM-05:00 PM in A-1
2025-12-04
Accompanied a study order, see S2790
Versions
- Bill TextCompare
Documents
Votes
Not provided by source.
Related bills
- Replaces: SD 1408
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=S 1603. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.